Zealand Pharma Presents Data from Phase 1 Trial of Dapiglutide at the 82nd Annual American Diabetes Association Scientific Sessions and Announces Dapiglutide to Move into Phase 2 Trial for Obesity

https://www.globenewswire.com/news-release/2022/06/06/2457233/0/en/Zealand-Pharma-Presents-Data-from-Phase-1-Trial-of-Dapiglutide-at-the-82nd-Annual-American-Diabetes-Association-Scientific-Sessions-and-Announces-Dapiglutide-to-Move-into-Phase-2-T.html

press release